| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2011-11-07 | EV-077 | complications of diabetes | 2a | Evolva (Switzerland) | Metabolic diseases |
| 2011-11-05 | miravirsen | hepatitis C | 2a | Santaris Pharma (Denmark) | Infectious diseases |
| 2011-11-05 | Ragweed AIT | 3 | Merck&Co (USA) ALK Abello (Denmark) | Allergic diseases - Immune diseases | |
| 2011-11-05 | Debio 025 (alisporivir) | Hepatitis C | 2 | Novartis (Switzerland) | Infectious diseases |
| 2011-11-03 | PLX-PAD cells | Critical Limb Ischemia | 1 | Pluristem Therapeutic (Israel) | Cardiovascular diseases |
| 2011-11-02 | simeprevir (TMC435) |
| 2b | Medivir (Sweden) Tibotec (J&J group) | Infectious diseases |
| 2011-11-01 | Dekavil | rheumatoid arthritis | 1 | Philogen (Italy) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2011-10-26 | AclarusDx™ | Alzheimer disease | pilot | Exonhit (France) | Neurodegenerative diseases |
| 2011-10-25 | investigational levonorgestrel-releasing intrauterine systems (IUSs), LNG-IUS12 and LNG-IUS16 | contraception |
3 | Bayer (Germany) | Gynecology - Women's health |
| 2011-10-24 | linaclotide | irritable bowel syndrome with constipation (IBS-C) | 3 | Almirall (Spain) | Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
| 2011-10-21 | Venvanse® (US brand name Vyvanse®) lisdexamfetamine dimesylate | Attention-Deficit Hyperactivity Disorder (ADHD) |
3 | Shire (UK-USA) | Mental diseases - CNS diseases |
| 2011-10-18 | Herceptin® IV (trastuzumab) | HER2-positive early breast cancer. | 3 | Roche (Switzerland) | Cancer Oncology |
| 2011-10-18 | UshStat® | Usher syndrome type 1B | 1-2a | Oxford Biomedica (UK) | Ophtalmology |
| 2011-10-18 | silica-based drug delivery platform | 1 | FORMAC Pharmaceuticals (Belgium) | ||
| 2011-10-17 | masitinib | multiple myeloma | 3 | AB Science (France) | |
| 2011-10-12 | ST10 | iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease (IBD). |
3 | Shield Therapeutics (UK) | Hematological diseases - Inflammatory diseases |
| 2011-10-11 | talactoferrin | non-small cell lung cancer | 2 | Agennix (Germany) | Cancer Oncology |
| 2011-09-30 | PNB01 | major depressive disorder (MDD) |
3 | PharmaNeuroBoost (Belgium) | CNS diseases - Mental diseases |
| 2011-09-28 | V158866 (fatty acid amide hydrolase (FAAH) inhibitor) | pain | 1 | Vernalis (UK) | CNS diseases |
| 2011-09-27 | aclidinium bromide | chronic obstructive pulmonary disease (COPD) | 3 | Almirall (Spain) | Respiratory diseases |
